REJECTION MECHANISM AND IMMUNOSUPPRESSIVE STRATEGY OF SMALL BOWEL TRANSPLANTATION.

小肠移植的排斥机制和免疫抑制策略。

基本信息

  • 批准号:
    09671835
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1999
  • 项目状态:
    已结题

项目摘要

The p38 mitogen-activated protein kinase (MAPK) is a stress-activated enzyme responsible for transducing inflammatory signals. On CD8+ T lymphocytes, p38 expression correlates with cytotoxic activity. Concerning apoptotic signaling pathways, p38 is activated by TNF-α and activation of p38 may induce apoptosis. Methods. Heterotopic small bowel transplantation (SBT) was performed. Group1. LEW → LEW (n=3), Group2. BN → LEW (n=5, no treatment), Group3, BN → LEW (n=3, FK506 0.5 mg/kg, i.m.for 7 days). Group4 BN → LEW (n=3, anti-TNF-α antibody ; 1.0mg/kg, i.p.injection at SBT). Histology, apoptosis, immunostaining of p38 and phosphospecific p38, and Western blot of phosphospecific p38 were examined. Results. The histopathologic findings of Group 1 on day 7 after transplantation, moderate to serve rejection was observed in Group 2. On the other hand, Group 3 and 4 on day 7 after transplantation showed mild to moderate rejection. The graft infiltrating CD8a/p38-double positive cells in Group 2 significantly increased compared with Group3. Concerning TUNEL-positive cells 10 HPF by Mann-Whitney U-test, there were more positive cells in Group 2 (9.4±3.6) than in Group 1 (0.7±0.6) (p=0.024). However, the number of positive cells in Group 4 (4.3±1.5) decreased significantly compared with Group 2 (p=0.047). There was no significant difference in the number of cells expressing p38 among four groups. In expression of phosphospecific p38, the numbers of positive cells in Group 2 seemed like more than that in Group 4. In the western blotting of phosphospecific p38 in rejecting allografts, immunoreactive bands in Group 2 were detected stronger than that in Group 4. Conclusions. Since the infiltrating cells at allograft rejection would predominantly express phosphospecific p38, combined FK506 and anti-TNF antibody therapy might success by suppressing the activation of p38.
p38丝裂原活化蛋白激酶(MAPK)是一种应激活化酶,负责传导炎症信号。在CD 8 + T淋巴细胞上,p38表达与细胞毒活性相关。关于凋亡信号通路,p38被TNF-α激活,并且p38的激活可诱导凋亡。方法.行异位小肠移植(SBT)。第1组。LEW → LEW(n=3),组2。BN → LEW(n=5,未处理),组3,BN → LEW(n=3,FK 506 0.5 mg/kg,肌肉注射,连续7天)。4组BN → LEW(n=3,抗TNF-α抗体,1.0mg/kg,SBT时腹腔注射)。组织学、细胞凋亡、p38和磷酸化p38的免疫染色以及磷酸化p38的Western blot检测。结果移植后第7天,第1组的组织病理学结果显示,第2组出现中度至重度排斥反应。另一方面,第3组和第4组在移植后第7天表现出轻度至中度排斥反应。第2组移植物浸润的CD 8a/p38双阳性细胞较第3组显著增加。关于通过Mann-Whitney U检验的TUNEL阳性细胞10 HPF,第2组(9.4±3.6)中的阳性细胞多于第1组(0.7±0.6)(p=0.024)。然而,与第2组相比,第4组中的阳性细胞数量(4.3±1.5)显著减少(p=0.047)。四组间p38表达细胞数无显著性差异。磷酸化特异性p38蛋白的表达,第2组阳性细胞数多于第4组。在排斥移植物中磷酸化特异性p38的免疫印迹中,组2中检测到的免疫反应条带强于组4。结论.由于在同种异体移植排斥反应中浸润细胞主要表达磷酸化特异性p38,FK 506和抗TNF抗体联合治疗可能通过抑制p38的活化而成功。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KANEHIRO Hiromichi其他文献

KANEHIRO Hiromichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KANEHIRO Hiromichi', 18)}}的其他基金

New transplantation strategy of gut like organ differentiation from pluripotent stem cells by tissue engineering
通过组织工程从多能干细胞分化肠样器官的新移植策略
  • 批准号:
    24592699
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New treatment strategy for Hirschsprung's disease with neural crest stem cells by tissue-engneering
组织工程神经嵴干细胞治疗先天性巨结肠症的新策略
  • 批准号:
    21592280
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of graft injury and regeneration in small bowel transplantation
小肠移植损伤与再生机制
  • 批准号:
    19592065
  • 财政年份:
    2007
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
THERAPEUTIC POTENTIAL OF TARGETING ANIGIOGENESIS IN CHRONIC REJECTION AND ISCHEMIA-REPERFUSION INJURY IN SMALL BOWEL TRANSPLANTATION
小肠移植中慢性排斥和缺血再灌注损伤中靶向血管生成的治疗潜力
  • 批准号:
    17591867
  • 财政年份:
    2005
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLE OF ANGIOGENESIS AND POTENTIAL OF ANTIANGIOGENESIS AS POSTTRANPLANT TREATMENT IN SMALL BOWEL TRANSPLANTATION
血管生成的作用以及抗血管生成作为小肠移植术后治疗的潜力
  • 批准号:
    15591891
  • 财政年份:
    2003
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
TORELANCE INDUCTION AND IMMUNOSUPPRESSIVE STERATEGY OF SMALL BOWEL TRANSPLANTATION.
小肠移植的 TOrelance 诱导和免疫抑制策略。
  • 批准号:
    12671741
  • 财政年份:
    2000
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MECHANISM OF TRANSPLANT CHIMERISM AND SIGNIFICANCE OF MIGRATION OF DONOR-DERIVED CELLS IN ORGAN
移植嵌合机制及供体来源细胞在器官中迁移的意义
  • 批准号:
    05671020
  • 财政年份:
    1993
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Identification of therapeutic strategies for melanomas with rare mitogen-activated protein kinase (MAPK) mutations.
鉴定具有罕见丝裂原激活蛋白激酶 (MAPK) 突变的黑色素瘤的治疗策略。
  • 批准号:
    488142
  • 财政年份:
    2022
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Studentship Programs
Investigating the role of glutamate in mitogen-activated protein kinase inhibitor-resistant melanoma and its effects on CD8+ T cell subsets and response to anti-PD1 immunotherapy
研究谷氨酸在丝裂原激活蛋白激酶抑制剂耐药性黑色素瘤中的作用及其对 CD8 T 细胞亚群和抗 PD1 免疫治疗反应的影响
  • 批准号:
    449743
  • 财政年份:
    2020
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Studentship Programs
Suppression of a specific branch of mitogen-activated protein kinase (MAPK) signaling by bacterial AvrRpt2-like cysteine proteases: Mechanistic elucidation and application for MAPK studies.
细菌 AvrRpt2 样半胱氨酸蛋白酶抑制丝裂原激活蛋白激酶 (MAPK) 信号传导的特定分支:MAPK 研究的机制阐明和应用。
  • 批准号:
    327033184
  • 财政年份:
    2016
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Research Grants
Relationship of the mitogen-activated protein kinase with skeletal muscle fiber size and the changes of fiber type composition
丝裂原激活蛋白激酶与骨骼肌纤维大小及纤维类型组成变化的关系
  • 批准号:
    15K01620
  • 财政年份:
    2015
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
IDENTIFYING CARDIAC SUBSTRATES OF p38alpha MITOGEN-ACTIVATED PROTEIN KINASE
鉴定 p38α 丝裂原激活蛋白激酶的心脏底物
  • 批准号:
    MR/J007501/1
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Research Grant
The role of mitogen-activated protein kinase phosphatase-1 in tumor progression
丝裂原激活蛋白激酶磷酸酶-1在肿瘤进展中的作用
  • 批准号:
    8540102
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
The role of mitogen-activated protein kinase phosphatase-1 in tumor progression
丝裂原激活蛋白激酶磷酸酶-1在肿瘤进展中的作用
  • 批准号:
    8712204
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
The role of mitogen-activated protein kinase phosphatase-1 in tumor progression
丝裂原激活蛋白激酶磷酸酶-1在肿瘤进展中的作用
  • 批准号:
    8397228
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
The role of mitogen-activated protein kinase phosphatase-1 in tumor progression
丝裂原激活蛋白激酶磷酸酶-1在肿瘤进展中的作用
  • 批准号:
    8896303
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
STUDIES OF INHIBITION OF MITOGEN ACTIVATED PROTEIN KINASE 1 (ERK2)
丝裂原激活蛋白激酶 1 (ERK2) 抑制的研究
  • 批准号:
    8362294
  • 财政年份:
    2011
  • 资助金额:
    $ 1.6万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了